PPMI seeks to understand how Parkinson’s disease starts and changes over time, who gets it and why. It follows people both with and without Parkinson’s to learn more about these processes. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials for new drug development to treat or even prevent PD before it begins.